Trials / Completed
CompletedNCT00414011
Comparison of the Effect of 4th Generation Fluoroquinolones, Gatifloxacin and Moxifloxacin, on Epithelial Healing Following Photorefractive Keratectomy (PRK), A Substudy of: Initial Evaluation of Excimer Laser Keratorefractive Surgery in U.S. Army Personnel (WU # 2335-99)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Walter Reed Army Medical Center · Federal
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is a prospective,double-blinded, randomized trial to compare the rate of healing following PRK after the use of two commercially available 4th generation fluoroquinolones, moxifloxacin and gatifloxacin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Moxifloxacin | 1 drop 4 times daily for 1 week or until complete re-epithelization (usually 3-4 days) after surgery |
| DRUG | Gatifloxacin | 1 drop 4 times daily for 1 week or until complete re-epithelization (usually 3-4 days) after surgery |
Timeline
- Primary completion
- 2005-02-01
- Completion
- 2005-02-01
- First posted
- 2006-12-20
- Last updated
- 2013-07-17
- Results posted
- 2013-06-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00414011. Inclusion in this directory is not an endorsement.